Antiperspirant Above Women Dolce
Above Women Dolce
Baston Indstria De Aerossis Ltda
Human Otc Drug
NDC 73306-1127Antiperspirant Above Women Dolce also known as Above Women Dolce is a human otc drug labeled by 'Baston Indstria De Aerossis Ltda'. National Drug Code (NDC) number for Antiperspirant Above Women Dolce is 73306-1127. This drug is available in dosage form of Aerosol. The names of the active, medicinal ingredients in Antiperspirant Above Women Dolce drug includes Aluminum Sesquichlorohydrate - 24 g/100g . The currest status of Antiperspirant Above Women Dolce drug is Active.
Drug Information:
| Drug NDC: | 73306-1127 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Antiperspirant Above Women Dolce |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Above Women Dolce |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Baston Indstria De Aerossis Ltda |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Aerosol |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ALUMINUM SESQUICHLOROHYDRATE - 24 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 10 Sep, 2020 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 19 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part350 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Baston Indstria de Aerossis LTDA
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 7899674026989
|
| UPC stands for Universal Product Code. |
| UNII: | UCN889409V
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 73306-1127-1 | 90 g in 1 CAN (73306-1127-1) | 10 Sep, 2020 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Antiperspirant
Product Elements:
Antiperspirant above women dolce above women dolce glycerin polyglyceryl-3 diisostearate acorus calamus root butane propane aluminum sesquichlorohydrate aluminum sesquichlorohydrate levant cotton seed coconut allantoin green tea leaf dimethicone argan oil water cinnamon bark oil macadamia oil alpha-tocopherol acetate vinyl dimethicone/methicone silsesquioxane crosspolymer myrrh oil shea butter aloe vera leaf silica dimethyl silylate lecithin, soybean glyceryl monostearate chamomile isobutane disteardimonium hectorite isopropyl myristate avocado oil cyclomethicone 5 propylene carbonate yellow ish to yellow
Indications and Usage:
Uses - reduces underarm wetness
Warnings:
Flammable until fully dry. do not use near heat, flame or while smoking. can cause serious injury or deat. keep away from face and mouth to avoid breathing in. avoid spraying in eyes. contents under preassure. do not puncture ou incinerate. do not expose to heat or store at temperatures above 120 °f/ 50°c ou in enclosed places that could overheat. do not use on broken skin. stop use if rash or irritation accours. get medical attention immediately. ask a doctor before using if you have kidney disease. keep out of reac of children and animals. use only as direct. intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal. avoid the inhalation of the product. in case of contact with eyes, rinse whit planty of water. is swallowed , do not induce vomiting. consulte your healthcare provider immediatly. do not leave the aerosol container in a vehicle, risk of leakage and explosion. container material: steel. batch and expiration on bottom of the c
Read more...ontainer. help stop the inhalation abuse: www.inhalant.org
Dosage and Administration:
Directions - apply to underaerms only
Package Label Principal Display Panel:
Antitranspirante above women dolce
Further Questions:
E-mail sac@baston.com.br or call: +1(305)677-5030